Name: Tvardi Therapeutics, Inc. (TVRD) Financial Statements
Creator: FinSpry

Tvardi Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tvardi Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	7.14	0.00	0.00
Cost of Revenue	0.81	0.00	0.00
Gross Profit	6.33	0.00	0.00
Operating Expenses
Research & Development	23.65	15.87	18.47
Selling, General & Administrative	4.46	2.80	2.73
Operating Expenses	28.11	18.67	21.19
Operating Income	-28.11	-18.67	-21.19
Other Income/Expense
Interest Income	0.75	1.32	0.65
Interest Expense	8.47	0.00	0.00
Other Income/Expense	-2.04	0.00	0.00
Income
Income Before Tax	-29.40	-17.35	-20.54
Income Tax Expense	-0.40	0.00	0.00
Net Income	-29.40	-17.35	-20.54
Net Income - Continuous Operations	-70.87	-17.35	-20.54
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-28.01	-18.57	-20.45
EBIT	-28.11	-18.67	-20.54
Depreciation & Amortization	0.10	0.10	0.09
Earnings Per Share
Basic EPS	-5.00	-3.00	-2.00
Diluted EPS	-5.00	-3.00	-2.00
Basic Shares Outstanding	6.40	6.38	9.36
Diluted Shares Outstanding	6.40	6.38	9.36